Brain zaps for ADHD? new study tests iTBS in children
NCT ID NCT07182344
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether a non-invasive brain stimulation technique called iTBS can improve attention and self-control in children aged 6 to 12 with ADHD. Over two weeks, 40 children will receive either real or sham stimulation, and researchers will measure changes in attention using computer tasks, brain scans, and genetic tests. The goal is to see if iTBS helps and who might benefit most.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
intermittent theta burst stimulation (iTBS) delivered via a device to the brain
What this could lead to
If it works, this could point toward a non-drug treatment to help children with ADHD improve attention and self-control.
What could go wrong
This is a small, early-stage study with only 40 participants, so results may not apply to all children with ADHD. The treatment is short-term and may not produce lasting benefits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADHD - ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Neurolab Plus
Almaty, 050000, Kazakhstan
-
Non-profit joint-stock company "Al-Farabi Kazakh National University"
Almaty, 050040, Kazakhstan